Inappropriate use of carbamazepine and vigabatrin in typical absence seizures

Developmental Medicine and Child Neurology

Volumn 40, Issue 8, 1998, Pages 517-519

  Parker, A P J ^a   Agathonikou, A ^a   Robinson, R O ^a   Panayiotopoulos, C P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; LAMOTRIGINE; VALPROIC ACID; VIGABATRIN;

ARTICLE; CHILD; CLINICAL ARTICLE; EPILEPSY; FEMALE; HUMAN; MALE; MYOCLONUS; PRIORITY JOURNAL; RASH; SEIZURE; TREATMENT OUTCOME;

EID: 0031664882     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-8749.1998.tb15409.x     Document Type: Article

References (12)

1. Appleton RE. (1996) New antiepileptic drugs. Archives of Disease in Childhood 75: 256-62.
2. British National Formulary. 34th edn. (1997) London: British Medical Association.
3. Cereghino JJ, Brock JT, van Meter JC, Penry JK, Smith LD, White BG. (1974) Carbamazepine for epilepsy: a controlled prospective evaluation. Neurology 24: 401-10.
4. Duncan JS, Panayiotopoulos CP, editors. (1995) Typical Absences and Related Syndromes. London: Churchill Communications.
5. Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CY. (1995) Lamotrigine as an add on drug in typical absences. Acta Neurologica Scandinavica 91: 200-2.
6. _(1995) The clinical efficacy of vigabatrin in children. Review of Contemporary Pharmacotherapy 4: 469-76.
7. Horn S, Ater SB, Hurst DL. (1986) Carbamazepine exacerbated epilepsy in children and adolescents. Pediatric Neurology 2: 340-5.
8. Hosford DA, Wang Y. (1997) Utility of the lethargic (1h/1h) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tigabine, gabapentin, and topiramate against human absence seizures. Epilepsia 38: 408-14.
9. Joyce C. (1992) Carbamazepine is not for petit mal seizures. American Pharmacy NS32: 6.
10. Panayiotopoulos CP. (1997) Absence Epilepsies. In: Engel JJ, Pedley TA, editors. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven. p 2327-46.
11. _Agathonikou A, Sharoqi IA, Parker APJ. (1997) Vigabatrin aggravates absences and absence status. Neurology 49: 1467.
12. Physicians' Desk Reference. 51st edn. (1997) Montvale, NJ: Medical Economics.